Greenphire CEO Selected as Finalist in Ernst & Young Awards
News May 17, 2013
The awards recognize entrepreneurs that create and build market-leading businesses, taking standards of excellence to new heights and helping to transform the face of their respective industries. Sam was chosen from over 70 executives as a finalist for his achievements in building Greenphire into an industry leader.
Sam Whitaker, CEO of Greenphire, comments, "I am delighted to have been selected as a finalist by Ernst & Young and to be honored along with fellow nominees. As Greenphire grows and expands internationally, it is gratifying to be recognized for our successes in transforming outdated processes in the clinical trials industry. It would not have been possible without the tireless work of all the team members at Greenphire."
Since founding Greenphire, Sam has leveraged his entrepreneurial vision to simplify processes within clinical studies, replacing burdensome manual methods with platform-driven tools that execute complex payment processes globally. In five years he has built Greenphire from a two-person concept-driven start-up to an established player in the industry. The company now employs approximately 50 people on two continents.
Awards will be presented at a black tie gala on June 20 at the Pennsylvania Convention Center.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE